Loading clinical trials...
Loading clinical trials...
Activating Receptors and DAP12 Protein in Wegener's Granulomatosis
Conditions
Interventions
Physiopathology Endpoint Classification
Locations
1
France
Medecine Interne Hôpital Saint Louis
Paris, France
Start Date
May 1, 2010
Primary Completion Date
November 1, 2013
Completion Date
September 1, 2014
Last Updated
April 21, 2015
NCT02108860
NCT02115997
NCT01988506
NCT00104299
NCT00468208
NCT00307671
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions